TECH vs VTRS · P/E 65, rev $1.22B vs rev $14.74B
Bio-Techne Corp (TECH) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the TECH and VTRS stock pages for the full models.
Not investment advice.